Mast cell tryptase Antibody (YA5690)

Art. -Nr.: HY-P85998: Data Sheet User Guide for Antibodies
FAQs
Technical Support

Mast cell tryptase Antibody (YA5690) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Mast cell tryptase.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

Größe		Verfügbarkeit
50 μL		Angebot einholen
100 μL		Angebot einholen

* Bitte wählen Sie Menge, bevor Sie Artikel hinzufügen.

WB: Western Blot;
IHC-P: Immunohistochemistry-Paraffin;
IHC-F: Immunohistochemistry-Frozen;
ICC/IF: Immunocytochemistry/Immunofluorescence;
IF-Tissue: Immunofluorescence-Tissue;
mIHC: Multiplex Immunohistochemical;
IP: Immunoprecipitation;
ChIP: Chromatin Immunoprecipitation;
FC: Flow Cytometry;
ELISA: Enzyme Linked Immunosorbent Assay

Product Detail
Background
Beschreibung

Beschreibung

Mast cell tryptase Antibody (YA5690) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to Mast cell tryptase.

Host

Mouse

Clonality

Monoclonal

Molekulargewicht

Predicted band size: 30 kDa;

Observed band size: 30 kDa

Note: Due to possible protein modifications or aggregation, the molecular weight should be confirmed by actual measurement, and the predicted value is for reference only.

Species Reactivity

Human

SwissProt ID

Q15661

Gene ID

7177 [NCBI]

Immunogen

Synthesized peptide derived from human Mast cell tryptase AA range: 200-275

Application &
Dilution Ratio

Application	Dilution Ratio
IHC-P IHC-P: Immunohistochemistry-Paraffin	1:200-400
ICC/IF ICC/IF: Immunocytochemistry/Immunofluorescence	1:50-200
ELISA ELISA: Enzyme Linked Immunosorbent Assay	1:500-5000

Reinheit	affinity chromatography.	Conjugation	Non-conjugated
Modification	Unmodified	Isotype	IgG1

Appearance

Liquid

Formulation

Supplied in PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA

Storage & Stability

Stored at -20°C for 1 year. Avoid repeated freeze / thaw cycles.

Versand

Shipping with blue ice.

Background

Function：Tryptase is the major neutral protease present in mast cells and is secreted upon the coupled activation-degranulation response of this cell type. May play a role in innate immunity. Isoform 2 cleaves large substrates, such as fibronectin, more efficiently than isoform 1, but seems less efficient toward small substrates (PubMed:18854315)

Subcellular Localization：Secreted

Expression：
Tissue_specificity:Isomer 1 and isomer 2 are expressed in the lungs, stomach, spleen, heart, and skin; in these tissues, isomer 1 is dominant. Isomer 2 is expressed in aortic, splenic, and breast tumors, with the highest expression levels in endothelial cells of certain vessels around the aorta and in endothelial cells around tumors, while expression levels are very low (at the protein level) in mast cells.

Isoforms & Post-Translational Modification：Q15661 has 2 isomers: Q15661-1: 30515 Da (predicted); Q15661-2: 29533 Da (predicted).

Subunit：Homotetramer. The active tetramer is converted to inactive monomers at neutral and acidic pH in the absence of heparin. Low concentrations of inactive monomers become active monomers at pH 6.0 in the presence of heparin. When the concentration of active monomers is higher, they convert to active monomers and then to active tetramers. These monomers are active and functionally distinct from the tetrameric enzyme. In contrast to the hidden active sites in the tetrameric form, the active site of the monomeric form is accessible for macromolecular proteins and inhibitors, e.g. fibrinogen which is a substrate for the monomeric but not for the tetrameric form. The monomeric form forms a complex with SERPINB6

Dokumentation

User Guide for Antibodies (1077 KB)